Matches in SemOpenAlex for { <https://semopenalex.org/work/W2794394009> ?p ?o ?g. }
- W2794394009 endingPage "3" @default.
- W2794394009 startingPage "1" @default.
- W2794394009 abstract "Heavy menstrual bleeding (HMB), which affects as many as 30% of women, has a well- established negative impact on quality of life and work productivity [ 1 Lukes A.S. Baker J. Eder S. Adomako T.L. Daily menstrual blood loss and quality of life in women with heavy menstrual bleeding. Womens Health. 2012; 8: 503-511 Crossref PubMed Scopus (24) Google Scholar , 2 Singh S. Best C. Dunn S. Leyland N. Wolfman W.L. Abnormal uterine bleeding in premenopausal woman. SOGC Clinical Practice Guideline 292. J Obstet Gynecol Can. 2013; 35: S1-S28 PubMed Scopus (38) Google Scholar ]. In women with chronic HMB in the absence of known anatomic abnormalities (fibroids, adenomyosis), options such as non-steroidal anti-inflammatory drugs (NSAIDs) [ [3] Lethaby A. Duckitt K. Farquhar C. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2013; 000400 Google Scholar ], combined hormonal contraceptives [ [4] Jensen J.T. Parke S. Mellinger U. Machlitt A. Fraser I.S. Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial. Obstet Gynecol. 2011; 117: 777-787 Crossref PubMed Scopus (101) Google Scholar ], the levonorgestrel intrauterine system [ [5] Mansour D. Modern management of abnormal uterine bleeding—the levonorgestrel intra-uterine system. Best Pract Res Clin Obstet Gynaecol. 2007; 21: 1107-1121 Crossref Scopus (36) Google Scholar ], danazol [ [6] Chimbira T.H. Anderson A.B.M. Naish C. Cope E. Turnbull A.C. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo. Br J Obstet Gynaecol. 1980; 87: 1152-1158 Crossref PubMed Scopus (68) Google Scholar ] and tranexamic acid [ [7] Lukes A.S. Moore K.A. Muse K.N. Gersten J.K. Hecht B.R. Edlund M. et al. Tranexamic acid treatment for heavy menstrua lbleeding: a randomized controlled trial. Obstet Gynecol. 2010; 116: 865-875 Crossref PubMed Scopus (181) Google Scholar ] show varying degrees of efficacy for reduction of menstrual flow and are often able to restore normal day-to-day function." @default.
- W2794394009 created "2018-03-29" @default.
- W2794394009 creator A5014144073 @default.
- W2794394009 creator A5073181970 @default.
- W2794394009 creator A5078701210 @default.
- W2794394009 date "2018-07-01" @default.
- W2794394009 modified "2023-10-14" @default.
- W2794394009 title "Heavy menstrual bleeding: is tranexamic acid a safe adjunct to combined hormonal contraception?" @default.
- W2794394009 cites W131193627 @default.
- W2794394009 cites W1577907809 @default.
- W2794394009 cites W1880788620 @default.
- W2794394009 cites W1891641322 @default.
- W2794394009 cites W1974618393 @default.
- W2794394009 cites W2005968568 @default.
- W2794394009 cites W2014551224 @default.
- W2794394009 cites W2016753959 @default.
- W2794394009 cites W2021760239 @default.
- W2794394009 cites W2039788090 @default.
- W2794394009 cites W2047661631 @default.
- W2794394009 cites W2050208180 @default.
- W2794394009 cites W2050772002 @default.
- W2794394009 cites W2052706875 @default.
- W2794394009 cites W2068495515 @default.
- W2794394009 cites W2078480500 @default.
- W2794394009 cites W2091149074 @default.
- W2794394009 cites W2118699303 @default.
- W2794394009 cites W2120478116 @default.
- W2794394009 cites W2135918001 @default.
- W2794394009 cites W2143793800 @default.
- W2794394009 cites W2321973160 @default.
- W2794394009 cites W2549534579 @default.
- W2794394009 cites W2554695882 @default.
- W2794394009 cites W2594386877 @default.
- W2794394009 cites W2607870311 @default.
- W2794394009 cites W3091862444 @default.
- W2794394009 cites W4241168317 @default.
- W2794394009 doi "https://doi.org/10.1016/j.contraception.2018.02.008" @default.
- W2794394009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29477633" @default.
- W2794394009 hasPublicationYear "2018" @default.
- W2794394009 type Work @default.
- W2794394009 sameAs 2794394009 @default.
- W2794394009 citedByCount "17" @default.
- W2794394009 countsByYear W27943940092019 @default.
- W2794394009 countsByYear W27943940092020 @default.
- W2794394009 countsByYear W27943940092021 @default.
- W2794394009 countsByYear W27943940092022 @default.
- W2794394009 countsByYear W27943940092023 @default.
- W2794394009 crossrefType "journal-article" @default.
- W2794394009 hasAuthorship W2794394009A5014144073 @default.
- W2794394009 hasAuthorship W2794394009A5073181970 @default.
- W2794394009 hasAuthorship W2794394009A5078701210 @default.
- W2794394009 hasConcept C126322002 @default.
- W2794394009 hasConcept C131872663 @default.
- W2794394009 hasConcept C141071460 @default.
- W2794394009 hasConcept C2777164284 @default.
- W2794394009 hasConcept C2777416354 @default.
- W2794394009 hasConcept C2777486506 @default.
- W2794394009 hasConcept C2777687323 @default.
- W2794394009 hasConcept C2778001906 @default.
- W2794394009 hasConcept C2779076696 @default.
- W2794394009 hasConcept C2779522080 @default.
- W2794394009 hasConcept C2779637338 @default.
- W2794394009 hasConcept C2780186607 @default.
- W2794394009 hasConcept C2780566971 @default.
- W2794394009 hasConcept C2781418897 @default.
- W2794394009 hasConcept C2908647359 @default.
- W2794394009 hasConcept C29456083 @default.
- W2794394009 hasConcept C2986817661 @default.
- W2794394009 hasConcept C2991743468 @default.
- W2794394009 hasConcept C71924100 @default.
- W2794394009 hasConcept C99454951 @default.
- W2794394009 hasConceptScore W2794394009C126322002 @default.
- W2794394009 hasConceptScore W2794394009C131872663 @default.
- W2794394009 hasConceptScore W2794394009C141071460 @default.
- W2794394009 hasConceptScore W2794394009C2777164284 @default.
- W2794394009 hasConceptScore W2794394009C2777416354 @default.
- W2794394009 hasConceptScore W2794394009C2777486506 @default.
- W2794394009 hasConceptScore W2794394009C2777687323 @default.
- W2794394009 hasConceptScore W2794394009C2778001906 @default.
- W2794394009 hasConceptScore W2794394009C2779076696 @default.
- W2794394009 hasConceptScore W2794394009C2779522080 @default.
- W2794394009 hasConceptScore W2794394009C2779637338 @default.
- W2794394009 hasConceptScore W2794394009C2780186607 @default.
- W2794394009 hasConceptScore W2794394009C2780566971 @default.
- W2794394009 hasConceptScore W2794394009C2781418897 @default.
- W2794394009 hasConceptScore W2794394009C2908647359 @default.
- W2794394009 hasConceptScore W2794394009C29456083 @default.
- W2794394009 hasConceptScore W2794394009C2986817661 @default.
- W2794394009 hasConceptScore W2794394009C2991743468 @default.
- W2794394009 hasConceptScore W2794394009C71924100 @default.
- W2794394009 hasConceptScore W2794394009C99454951 @default.
- W2794394009 hasIssue "1" @default.
- W2794394009 hasLocation W27943940091 @default.
- W2794394009 hasLocation W27943940092 @default.
- W2794394009 hasOpenAccess W2794394009 @default.
- W2794394009 hasPrimaryLocation W27943940091 @default.
- W2794394009 hasRelatedWork W2005361418 @default.
- W2794394009 hasRelatedWork W2028726689 @default.